Evidence map›Paper›PMID 38205609›Full record

ArticleThe journal of vascular access2025

Implementation of a vascular access team and an intravenous therapy programme: A first-year activity analysis.

Arianna Rosich-Soteras, Carolina Bonilla-Serrano, Ma Àngels Llauradó-González, Alicia Fernández-Bombín, Joselyn Abigail Triviño-López, Lluís Barceló-Querol, Laura Heredia-Aguilar, Ma Carmen Frías-Martín, Montserrat Valverde-Bosch, Ma Lourdes Corominas-Bosch and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The journal of vascular access, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Arianna Rosich-SoterasOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0009-0003-3705-9540
Carolina Bonilla-SerranoOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.ORCID 0000-0002-9749-7847
Ma Àngels Llauradó-GonzálezInfusion and Vascular Access Team, Hospital Clínic Barcelona, Barcelona, Spain.
Alicia Fernández-BombínInfusion and Vascular Access Team, Hospital Clínic Barcelona, Barcelona, Spain.
Joselyn Abigail Triviño-LópezOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Lluís Barceló-QuerolAngioradiology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Laura Heredia-AguilarTrauma and Orthopaedic Surgery Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ma Carmen Frías-MartínGastroenterology and Digestive Surgery Department, Hospital Clínic Barcelona, Barcelona, Spain.
Montserrat Valverde-BoschOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ma Lourdes Corominas-BoschOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Ariadna DomènechOncology and Haematology Department, Hospital Clínic Barcelona, Barcelona, Spain.
Hospital Clínic de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCreating Vascular Access Teams (VAT) provides an expert nursing role that contributes to the training and continuous improvement of healthcare personnel. They can offer greater clinical safety, reducing complications and costs. Peripherally inserted central catheters (PICCs) and midline catheters (ML) can be safe and cost-effective alternatives to other types of venous access (VA). The aim of the study was to analyse our centre's VAT first 12 months of activity. The primary outcome was reported complications. Secondary outcomes were cause of catheter removal, consultancy activity and economic impact of VAT implantation. METHODOLOGY: A longitudinal, descriptive study was carried out from March 2019 to March 2020. Using consecutive sampling, all VA inserted, and all consults received were included. Patients under 18 years of age were excluded.

resultsThe VAT inserted 1257 catheters into 1056 patients (291 MLs, 966 PICCs). The mean dwell time was 14.9 days for MLs and 59.07 days for PICCs. The main reason for removing VA was end of treatment (80.7%). During VA follow-up confirmed infection was detected in 1 ML (0.3%) and nine PICCs (0.9%). Symptomatic thrombosis was reported in 2 MLs (0.7%) and 16 PICCs (1.7%). The VAT received 367 consultations, and the main reason for consultation was to resolve doubts regarding the management of VA (80.9%). The insertion of ML and PICC catheters represented annual estimated economic savings of €867,688.44€.

conclusionsOur study provides a detailed analysis of VAT's activity, its relevance to clinical safety, and to efficient resource management within our hospital. It demonstrates how VAT establishment can be a safe and efficient intervention that enhances care quality.

Indexed as

Catheterization, Central VenousCatheterization, PeripheralPatient Care TeamAdultAgedAged, 80 and overCatheter-Related InfectionsCatheters, IndwellingCentral Venous CathetersCost-Benefit AnalysisCost SavingsDevice RemovalFemaleHumansLongitudinal StudiesMalecatheter-related bloodstream infection (CRBSI)midline catheterperipherally inserted central catheter (PICC)thrombosisVascular AccessVascular Access Team

Identifiers

PMID38205609
PMCPMC11894895
OpenAlexW4390743430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.